Viewing Study NCT04300192


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-01-04 @ 5:18 PM
Study NCT ID: NCT04300192
Status: COMPLETED
Last Update Posted: 2025-09-12
First Post: 2020-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module